A peer-reviewed journal that offers evidence-based clinical information and continuing education for dentists.

Study Shows Injecting Monoclonal Antibodies Prevents COVID-19 Infection


A new study published in the New England Journal of Medicine shows that the injection of two monoclonal antibodies—casirivimab and imdevimab—significantly reduces risk of COVID-19 infection among those exposed to the virus. The research included participants who had been exposed to SARS-CoV-2 in their household within the past 96 hours. One group received the monoclonal antibody injection and the control group received a placebo. Those who received the injection were 72% less likely to develop COVID-19 within 1 week; this percentage grew to 93% 1 week after the injection was administered. The study was a randomized, double-blind, placebo-controlled clinical trial, which is at the top of the evidence pyramid. Click here to read more.

Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy